Philippe Roche
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Engineering SIRPα conformational plasticity to reveal a cryptic pocket suitable for structure-based drug design.
Journal: bioRxiv : the preprint server for biology
Published: January 07, 2026
NanoDSF Screening for Anti-tubulin Agents Uncovers New Structure-Activity Insights.
Journal: Journal of medicinal chemistry
Published: August 15, 2025
How closely do ecosystem services and life cycle assessment frameworks concur when evaluating contrasting animal-production systems with ruminant or monogastric species?
Journal: Animal : an international journal of animal bioscience
Published: April 08, 2024
ChemoDOTS: a web server to design chemistry-driven focused libraries.
Journal: Nucleic acids research
Published: March 11, 2024
The Recurrent Liver MAN2A1-FER Oncoprotein Lacks Kinase Activity: Implications for the Use of Tyrosine Kinase Inhibitors.
Journal: Cellular and molecular gastroenterology and hepatology
Published: December 04, 2023
Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein-Protein Interaction: A Semi-Automated "Hit Identification-to-Optimization" Approach.
Journal: Journal of medicinal chemistry
Published: March 20, 2023
Cinacalcet Reverses Short QT Interval in Familial Hypocalciuric Hypercalcemia Type 1.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 30, 2023
From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia.
Journal: Nature communications
Published: September 22, 2022
Discovery of Small-Molecule Inhibitors of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer.
Journal: ACS chemical biology
Published: April 28, 2022
CRCM5484: A BET-BDII Selective Compound with Differential Anti-leukemic Drug Modulation.
Journal: Journal of medicinal chemistry
Published: March 29, 2022
Rational Design of PDZ Domain Inhibitors: Discovery of Small Organic Compounds Targeting PDZ Domains.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 20, 2021
Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread.
Journal: European journal of medicinal chemistry
Published: March 22, 2021
Last Updated: 09/26/2026